MXPA05011594A - Intermediarios de imidazopiridina. - Google Patents
Intermediarios de imidazopiridina.Info
- Publication number
- MXPA05011594A MXPA05011594A MXPA05011594A MXPA05011594A MXPA05011594A MX PA05011594 A MXPA05011594 A MX PA05011594A MX PA05011594 A MXPA05011594 A MX PA05011594A MX PA05011594 A MXPA05011594 A MX PA05011594A MX PA05011594 A MXPA05011594 A MX PA05011594A
- Authority
- MX
- Mexico
- Prior art keywords
- intermediates
- imidazopyridine
- compounds
- substituents
- symbols
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invencion se refiere a compuestos de la formula (I), en la cual los sustituyentes y simbolos tienen los significados indicados en la descripcion. Los compuestos son intermediarios valiosos para la preparacion de compuestos farmaceuticos activos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03010218 | 2003-05-06 | ||
PCT/EP2004/050693 WO2004099203A1 (en) | 2003-05-06 | 2004-05-04 | Imidazopyridine intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05011594A true MXPA05011594A (es) | 2005-12-15 |
Family
ID=33427041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05011594A MXPA05011594A (es) | 2003-05-06 | 2004-05-04 | Intermediarios de imidazopiridina. |
Country Status (18)
Country | Link |
---|---|
US (1) | US7256293B2 (es) |
EP (1) | EP1622905A1 (es) |
JP (1) | JP2006525285A (es) |
KR (1) | KR20060015541A (es) |
CN (1) | CN1780834A (es) |
AR (1) | AR044129A1 (es) |
AU (1) | AU2004235981A1 (es) |
BR (1) | BRPI0410056A (es) |
CA (1) | CA2524259A1 (es) |
CL (1) | CL2004000951A1 (es) |
IS (1) | IS8151A (es) |
MX (1) | MXPA05011594A (es) |
NO (1) | NO20055699L (es) |
PE (1) | PE20050149A1 (es) |
RS (1) | RS20050811A (es) |
TW (1) | TW200504075A (es) |
WO (1) | WO2004099203A1 (es) |
ZA (1) | ZA200507861B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1611131E (pt) | 2003-02-27 | 2010-12-20 | Palau Pharma Sa | Derivados de pirazolopiridina |
US7470664B2 (en) | 2005-07-20 | 2008-12-30 | Merck & Co., Inc. | HCV NS3 protease inhibitors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU736767B2 (en) | 1997-05-28 | 2001-08-02 | Altana Pharma Ag | Fused dihydropyrans |
NZ520836A (en) | 2000-03-29 | 2005-01-28 | Altana Pharma Ag | Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders |
WO2001072756A1 (en) | 2000-03-29 | 2001-10-04 | Altana Pharma Ag | Prodrugs of imidazopyridine derivatives |
IL151198A0 (en) | 2000-03-29 | 2003-04-10 | Altana Pharma Ag | Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same |
MXPA02009552A (es) | 2000-03-29 | 2004-05-14 | Altana Pharma Ag | Derivados de imidazopiridina alquilada. |
EP1332143A1 (en) * | 2000-10-25 | 2003-08-06 | ALTANA Pharma AG | Polysubstituted imidazopyridines as gastric secretion inhibitors |
HUP0400380A3 (en) | 2001-08-03 | 2007-05-29 | Altana Pharma Ag | Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders and pharmaceuticals containing them |
EP1417208A1 (en) | 2001-08-03 | 2004-05-12 | ALTANA Pharma AG | Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
KR20040023739A (ko) | 2001-08-10 | 2004-03-18 | 알타나 파마 아게 | 삼환식 이미다조피리딘 |
-
2004
- 2004-04-29 AR ARP040101460A patent/AR044129A1/es not_active Application Discontinuation
- 2004-05-03 PE PE2004000444A patent/PE20050149A1/es not_active Application Discontinuation
- 2004-05-04 RS YUP-2005/0811A patent/RS20050811A/sr unknown
- 2004-05-04 CN CNA2004800114219A patent/CN1780834A/zh active Pending
- 2004-05-04 CA CA002524259A patent/CA2524259A1/en not_active Abandoned
- 2004-05-04 JP JP2006505586A patent/JP2006525285A/ja not_active Withdrawn
- 2004-05-04 BR BRPI0410056-5A patent/BRPI0410056A/pt not_active IP Right Cessation
- 2004-05-04 EP EP04731016A patent/EP1622905A1/en not_active Withdrawn
- 2004-05-04 MX MXPA05011594A patent/MXPA05011594A/es not_active Application Discontinuation
- 2004-05-04 US US10/555,057 patent/US7256293B2/en not_active Expired - Fee Related
- 2004-05-04 CL CL200400951A patent/CL2004000951A1/es unknown
- 2004-05-04 AU AU2004235981A patent/AU2004235981A1/en not_active Abandoned
- 2004-05-04 KR KR1020057020449A patent/KR20060015541A/ko not_active Application Discontinuation
- 2004-05-04 WO PCT/EP2004/050693 patent/WO2004099203A1/en active Application Filing
- 2004-05-05 TW TW093112688A patent/TW200504075A/zh unknown
-
2005
- 2005-09-28 ZA ZA200507861A patent/ZA200507861B/xx unknown
- 2005-11-25 IS IS8151A patent/IS8151A/is unknown
- 2005-12-02 NO NO20055699A patent/NO20055699L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR044129A1 (es) | 2005-08-24 |
US7256293B2 (en) | 2007-08-14 |
EP1622905A1 (en) | 2006-02-08 |
TW200504075A (en) | 2005-02-01 |
PE20050149A1 (es) | 2005-03-22 |
AU2004235981A1 (en) | 2004-11-18 |
NO20055699L (no) | 2006-01-17 |
WO2004099203A8 (en) | 2007-04-26 |
NO20055699D0 (no) | 2005-12-02 |
KR20060015541A (ko) | 2006-02-17 |
JP2006525285A (ja) | 2006-11-09 |
IS8151A (is) | 2005-11-25 |
WO2004099203A1 (en) | 2004-11-18 |
US20060276499A1 (en) | 2006-12-07 |
RS20050811A (en) | 2007-12-31 |
CN1780834A (zh) | 2006-05-31 |
ZA200507861B (en) | 2008-08-27 |
CA2524259A1 (en) | 2004-11-18 |
BRPI0410056A (pt) | 2006-05-23 |
CL2004000951A1 (es) | 2005-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05012025A (es) | Imidazo y tiazolopiridinas como inhibidores de cinasa jak3. | |
MXPA05012026A (es) | Compuestos de azaindol como inhibidores de cinasa. | |
DE602004021472D1 (en) | Pyrimiidinverbindungen | |
MXPA05009969A (es) | Metodo para aislar la forma cristalina i de la 5-azacitidina. | |
MY151455A (en) | Carbonylamino pyrrolopyrazoles, potent kinase inhibitors | |
MX2007013632A (es) | Procedimientos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo y sus productos intermedios. | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
MX2010003155A (es) | Derivados de ciclopropil aril amida y uso de los mismos. | |
UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
GB0508318D0 (en) | Organic compounds | |
TW200738659A (en) | Novel compounds | |
TW200638930A (en) | Acetylene derivatives | |
TW200609221A (en) | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them | |
MXPA06000936A (es) | Derivados de nicotinamida utiles como inhibidores de pde4. | |
GB0327323D0 (en) | Novel pharmaceuticals | |
MXPA05011594A (es) | Intermediarios de imidazopiridina. | |
GB0309440D0 (en) | Quinolone derivatives | |
TW200603801A (en) | Novel dialkoxy-imidazopyridines | |
DE60214004D1 (en) | Tricyclische epoxide | |
ES2268990A1 (es) | Compuestos quinonicos antitumorales y sus derivados, procedimiento de obtencion y sus aplicaciones. | |
DE602004013542D1 (en) | 2-phenylpyran-4-on-derivate als selektive cox-2 inhibitoren | |
ATE328883T1 (de) | Imidazopyridin-8-one | |
GB0314299D0 (en) | Chemical compounds | |
TW200531691A (en) | Tricyclic imidazopyridines and novel intermediates for the synthesis thereof | |
RS72004A (en) | Tryciclic n-acyl compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |